Content area

Abstract

The interplay between cortical and limbic regions in stress circuitry calls for a neural systems approach to investigations of acute stress responses in major depressive disorder (MDD). Advances in multimodal imaging allow inferences between regional neurotransmitter function and activation in circuits linked to MDD, which could inform treatment development. The current study investigated the role of the inhibitory neurotransmitter GABA in stress circuitry in females with current and remitted MDD. Multimodal imaging data were analyzed from 49 young female adults across three groups (current MDD, remitted MDD (rMDD), and healthy controls). GABA was assessed at baseline using magnetic resonance spectroscopy, and functional MRI data were collected before, during, and after an acute stressor and analyzed using a network modeling approach. The MDD group showed an overall lower cortisol response than the rMDD group and lower rostral anterior cingulate cortex (ACC) GABA than healthy controls. Across groups, stress decreased activation in the frontoparietal network (FPN) but increased activation in the default mode network (DMN) and a network encompassing the ventromedial prefrontal cortex–striatum–anterior cingulate cortex (vmPFC–Str–ACC). Relative to controls, the MDD and rMDD groups were characterized by decreased FPN and salience network (SN) activation overall. Rostral ACC GABA was positively associated with connectivity between an overlapping limbic network (Temporal–Insula–Amygdala) and two other circuits (FPN and DMN). Collectively, these findings indicate that reduced GABA in females with MDD was associated with connectivity differences within and across key networks implicated in depression. GABAergic treatments for MDD might alleviate stress circuitry abnormalities in females.

Details

Title
Reductions in rostral anterior cingulate GABA are associated with stress circuitry in females with major depression: a multimodal imaging investigation
Author
Ironside, Maria 1 ; Moser, Amelia D 2 ; Holsen, Laura M 3   VIAFID ORCID Logo  ; Zuo, Chun S 4 ; Du, Fei 5   VIAFID ORCID Logo  ; Perlo, Sarah 6 ; Richards, Christine E 6 ; Duda, Jessica M 6 ; Chen, Xi 5 ; Nickerson, Lisa D 4 ; Null, Kaylee E 6 ; Nascimento Nara 6 ; Crowley, David J 6 ; Misra Madhusmita 7 ; Goldstein, Jill M 8   VIAFID ORCID Logo  ; Pizzagalli, Diego A 9   VIAFID ORCID Logo 

 McLean Hospital, Center for Depression, Anxiety and Stress Research, Belmont, USA (GRID:grid.240206.2) (ISNI:0000 0000 8795 072X); Laureate Institute for Brain Research, Tulsa, USA (GRID:grid.417423.7) (ISNI:0000 0004 0512 8863) 
 McLean Hospital, Center for Depression, Anxiety and Stress Research, Belmont, USA (GRID:grid.240206.2) (ISNI:0000 0000 8795 072X); University of Colorado Boulder, Boulder, USA (GRID:grid.266190.a) (ISNI:0000000096214564) 
 Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Brigham & Women’s Hospital, Divison of Women’s Health, Department of Medicine, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294); Brigham & Women’s Hospital, Department of Psychiatry, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294) 
 Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); McLean Hospital, McLean Imaging Center, Belmont, USA (GRID:grid.240206.2) (ISNI:0000 0000 8795 072X) 
 Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); McLean Hospital, McLean Imaging Center, Belmont, USA (GRID:grid.240206.2) (ISNI:0000 0000 8795 072X); McLean Hospital, Schizophrenia and Bipolar Research Program, Belmont, USA (GRID:grid.240206.2) (ISNI:0000 0000 8795 072X) 
 McLean Hospital, Center for Depression, Anxiety and Stress Research, Belmont, USA (GRID:grid.240206.2) (ISNI:0000 0000 8795 072X) 
 Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Massachusetts General Hospital, Division of Pediatric Endocrinology, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924) 
 Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Massachusetts General Hospital, Department of Psychiatry, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924); Massachusetts General Hospital, Department of Obstetrics and Gynecology, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924) 
 McLean Hospital, Center for Depression, Anxiety and Stress Research, Belmont, USA (GRID:grid.240206.2) (ISNI:0000 0000 8795 072X); Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); McLean Hospital, McLean Imaging Center, Belmont, USA (GRID:grid.240206.2) (ISNI:0000 0000 8795 072X) 
Pages
2188-2196
Publication year
2021
Publication date
Nov 2021
Publisher
Nature Publishing Group
ISSN
0893133X
e-ISSN
1740634X
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2580808561
Copyright
© The Author(s), under exclusive licence to American College of Neuropsychopharmacology 2021.